September 11, 2023-September 13, 2023 View Now: 2023 Rare and Orphan Disease Conference presented by C-Path Patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists will
August 29, 2023 Externally-Led Patient Focused Drug Development C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) and the PKD Foundation will be hosting an Externally-Led Patient
August 17, 2023 C-Path to Host a Scientific Breakthrough Summit Oct. 26-27 Addressing Unmet Regulatory Needs and Drug Development Opportunities through Collaborations in Type 1 Diabetes, Alpha-1 Antitrypsi
August 15, 2023 NORDs’ IAMRARE Registry Contributes Two New Datasets to C-Path’s RDCA-DAP, Boosting Rare Disease Research and Therapeutic Advancement TUCSON, Ariz., August 15, 2023 — Critical Path Institute (C-Path) announced today that the National Organization for Rare Disord
August 10, 2023 View Now: Teaching Patients and Caregivers: The Role of Education in Research and Data Sharing Thursday, August 10, noon ET: This webinar will focus on the role of foundational education in research concepts, such as data lit
August 9, 2023 C-Path Welcomes Sanofi to its Type 1 Diabetes Consortium to Help Advance Drug Development The global immunology and diabetes leader will collaborate with C-Path’s T1DC to drive transformative change in type 1 diabe
August 9, 2023 C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy C-Path's Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce...
August 5, 2023-August 6, 2023 The Society of Critical Care Medicine’s Datathon Impact critical care in new ways at Society of Critical Care Medicine, SCCM, Datathon with CDRC’s Smith Heavner, PhD, RN! Th
July 25, 2023 Best Practice Recommendations for Electronic Patient-Reported Outcome (ePRO) Dataset Structure and Standardization to Support Drug Development
July 25, 2023 Longitudinal estimated glomerular filtration rate (eGFR) modeling in long-term renal function to inform clinical trial design in kidney transplantation Kidney transplantation is the preferred treatment for individuals with end-stage kidney disease. From a modeling perspective...
